Today’s clinicians use recombinant therapeutic proteins, such as monoclonal antibodies, to treat many diseases, from autoimmune disorders to cancer and beyond. Nonetheless, sequence variants (SVs), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback